Louise Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Louise Smith has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Georgina Williams
Midwifery and Palliative Care, Faculty of Nursing, King’s College London , London, SE5 9PJ
1 shared publication - Iwona Niec
Sickle Cell and Thalassaemia Team, Evelina London Children’s Hospital, St Thomas’ Hospital , London, SE1 7EH
1 shared publication - Iyamide Thomas
Sickle Cell Society , London, NW10 4UA
1 shared publication - Jane Chudleigh
Cicely Saunders Institute, King’s College London, London, SE1 8WA, UK
1 shared publication - Natalee Murray
Sickle Cell and Thalassaemia Team, Evelina London Children’s Hospital, St Thomas’ Hospital , London, SE1 7EH
1 shared publication - Nicholas Fordham
Paediatric Haematology, Evelina London Children’s Hospital, London, UK
1 shared publication
Latest Publications
- Open Access
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Co-designing a support strategy for caregivers to encourage early engagement with health services during the first year following their child’s diagnosis of sickle cell disease
Objective: To co-design a support strategy for caregivers during the first year following their child’s SCD diagnosis to encourage early engagement with health services. Methods: Principles of Experience-based Co-Design (EBCD) supported the study design. Interviews were conducted with caregivers of children with SCD and professionals involved in their care. Subsequent co-design workshops and a celebration event were held online to develop a co-designed animation. Results: Eighteen caregivers and 12 professionals were interviewed. Five themes were identified: information provision; negative implications associated with an SCD diagnosis; management of SCD; support for caregivers following a SCD diagnosis; and practical and social challenges. Fifteen caregivers and 9 professionals who were interviewed participated in 2 co-design workshops, and 9 caregivers and 9 professionals attended the celebration event. This led to the development of a co-designed animation to support caregivers during the first year following their child’s sickle cell diagnosis. Conclusion: This study demonstrates how EBCD can be used to translate caregivers’ and professionals’ experiences into a meaningful support resource for families following a child’s SCD diagnosis. Interview findings highlighted caregivers’ emotional shock at diagnosis, information overload, reliance on informal information sources, and the need for timely, practical, and trustworthy support. Professionals emphasized the importance of culturally sensitive communication, structured information, and early engagement with services. By meaningfully involving both groups, the co-designed animation directly addresses shared priorities. The animation offers an accessible form of early support and a scalable model for collaborative resource development across other stages of the sickle cell care journey. Clinical trial registration: NCT06251843.
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Open AccessCo-designing a support strategy for caregivers to encourage early engagement with health services during the first year following their child’s diagnosis of sickle cell disease
Objective: To co-design a support strategy for caregivers during the first year following their child’s SCD diagnosis to encourage early engagement with health services. Methods: Principles of Experience-based Co-Design (EBCD) supported the study design. Interviews were conducted with caregivers of children with SCD and professionals involved in their care. Subsequent co-design workshops and a celebration event were held online to develop a co-designed animation. Results: Eighteen caregivers and 12 professionals were interviewed. Five themes were identified: information provision; negative implications associated with an SCD diagnosis; management of SCD; support for caregivers following a SCD diagnosis; and practical and social challenges. Fifteen caregivers and 9 professionals who were interviewed participated in 2 co-design workshops, and 9 caregivers and 9 professionals attended the celebration event. This led to the development of a co-designed animation to support caregivers during the first year following their child’s sickle cell diagnosis. Conclusion: This study demonstrates how EBCD can be used to translate caregivers’ and professionals’ experiences into a meaningful support resource for families following a child’s SCD diagnosis. Interview findings highlighted caregivers’ emotional shock at diagnosis, information overload, reliance on informal information sources, and the need for timely, practical, and trustworthy support. Professionals emphasized the importance of culturally sensitive communication, structured information, and early engagement with services. By meaningfully involving both groups, the co-designed animation directly addresses shared priorities. The animation offers an accessible form of early support and a scalable model for collaborative resource development across other stages of the sickle cell care journey. Clinical trial registration: NCT06251843.